Optimizing expectations to prevent side effects and enhance quality of life in breast cancer patients undergoing endocrine therapy: study protocol of a randomized controlled trial

被引:53
作者
von Blanckenburg, Pia [1 ]
Schuricht, Franziska [1 ]
Albert, Ute-Susann [2 ]
Rief, Winfried [1 ]
Nestoriuc, Yvonne [3 ]
机构
[1] Univ Marburg, Dept Clin Psychol & Psychotherapy, D-35032 Marburg, Germany
[2] Univ Marburg, Breast Canc Ctr, Dept Gynecol Gynecol Endocrinol & Oncol, D-35032 Marburg, Germany
[3] Univ Hamburg, Dept Clin Psychol, Hamburg, Germany
关键词
Nocebo; Side effects; Prevention; Breast cancer; Endocrine therapy; RCT; ADJUVANT HORMONAL-THERAPY; EUROPEAN-ORGANIZATION; POSTMENOPAUSAL WOMEN; MENOPAUSAL SYMPTOMS; COMBINATION TRIAL; CLINICAL-TRIALS; ATAC ARIMIDEX; SHORT-FORM; ADHERENCE; QUESTIONNAIRE;
D O I
10.1186/1471-2407-13-426
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Background: Adjuvant endocrine therapy can improve disease-free survival and time before recurrence in breast cancer patients. However, it is associated with considerable side effects that negatively affect patients' quality of life and cause non-adherence. The recently demonstrated effect of individual expectations on side-effect development (nocebo effect) suggests that psychological factors play a role in the prevention of side effects. The aim of this study is to evaluate cognitive-behavioral side-effect prevention training (SEPT) for breast cancer patients. This article describes the study protocol and applied research methods. Methods/Design: In a randomized controlled trial, 184 female breast cancer patients are assigned to receive either SEPT, standard medical care or a manualized supportive therapy at the start of adjuvant endocrine treatment. SEPT consists of three sessions of cognitive-behavioral training including psychoeducation to provide a realistic view of endocrine therapy, imagination-training to integrate positive aspects of medication into daily life, and side-effect management to enhance expectations about coping ability. Side effects three months after the start of endocrine therapy serve as primary outcomes. Secondary outcomes include quality of life, coping ability and patients' medication adherence. Patients' expectations (i.e., expectations about side effects, coping ability, treatment and illness) are analyzed as mediators. Discussion: The optimization of expectations might be a potential pathway in health care to improve patients' quality of life during long-term medication intake. The results will provide implications for a possible integration of evidence-based prevention training into clinical practice.
引用
收藏
页数:10
相关论文
共 62 条
  • [41] Cognitive behavioural treatment for women who have menopausal symptoms after breast cancer treatment (MENOS 1): a randomised controlled trial
    Mann, Eleanor
    Smith, Melanie J.
    Hellier, Jennifer
    Balabanovic, Janet A.
    Hamed, Hisham
    Grunfeld, Elizabeth A.
    Hunter, Myra S.
    [J]. LANCET ONCOLOGY, 2012, 13 (03) : 309 - 318
  • [42] Margraf J., 1994, Mini-DIPS. Diagnostisches Kurz-Interview bei psychischen Storungen
  • [43] Markowitz John C, 2008, Am J Psychother, V62, P67
  • [44] Relationship of threat appraisal with coping appraisal to fear of cancer recurrence in breast cancer survivors
    McGinty, Heather L.
    Goldenberg, Jamie L.
    Jacobsen, Paul B.
    [J]. PSYCHO-ONCOLOGY, 2012, 21 (02) : 203 - 210
  • [45] Information provision for patients by breast cancer teams about the side-effects of hormone treatments
    McGurk, Rhona
    Fallowfield, Lesley
    Winters, Zoe
    [J]. EUROPEAN JOURNAL OF CANCER, 2006, 42 (12) : 1760 - 1767
  • [46] Fear of progression in breast cancer patients - validation of the short form of the Fear of Progression Questionnaire (FoP-Q-SF)
    Mehnert, Anja
    Herschbach, Peter
    Berg, Petra
    Henrich, Gerhard
    Koch, Uwe
    [J]. ZEITSCHRIFT FUR PSYCHOSOMATISCHE MEDIZIN UND PSYCHOTHERAPIE, 2006, 52 (03): : 274 - 288
  • [47] Fear of cancer progression and cancer-related intrusive cognitions in breast cancer survivors
    Mehnert, Anja
    Berg, Petra
    Henrich, Gerhard
    Herschbach, Peter
    [J]. PSYCHO-ONCOLOGY, 2009, 18 (12) : 1273 - 1280
  • [48] Clinical management of adverse events in adjuvant therapy for hormone-responsive early breast cancer
    Monnier, A.
    [J]. ANNALS OF ONCOLOGY, 2007, 18 : 36 - 44
  • [49] Prediction of Nonspecific Side Effects in Rheumatoid Arthritis Patients by Beliefs About Medicines
    Nestoriuc, Yvonne
    Orav, E. John
    Liang, Matthew H.
    Horne, Robert
    Barsky, Arthur J.
    [J]. ARTHRITIS CARE & RESEARCH, 2010, 62 (06) : 791 - 799
  • [50] Non-initiation of adjuvant hormonal therapy in women with hormone receptor-positive breast cancer: The Breast Cancer Quality of Care Study (BQUAL)
    Neugut, Alfred I.
    Hillyer, Grace Clarke
    Kushi, Lawrence H.
    Lamerato, Lois
    Leoce, Nicole
    Nathanson, S. David
    Ambrosone, Christine B.
    Bovbjerg, Dana H.
    Mandelblatt, Jeanne S.
    Magai, Carol
    Tsai, Wei-Yann
    Jacobson, Judith S.
    Hershman, Dawn L.
    [J]. BREAST CANCER RESEARCH AND TREATMENT, 2012, 134 (01) : 419 - 428